Is predicted to have ATP binding activity; DNA binding activity; and DNA helicase activity. Localizes to condensed chromosome and pronucleus. Is expressed in excretory cell; intestine; and uterus. Human ortholog(s) of this gene are implicated in autosomal dominant nonsyndromic deafness 70. Is an ortholog of human MCM2 (minichromosome maintenance complex component 2).
Is predicted to have 3-oxo-5-alpha-steroid 4-dehydrogenase activity and cholestenone 5-alpha-reductase activity. Is an ortholog of human SRD5A1 (steroid 5 alpha-reductase 1).
Is predicted to have 3-oxo-5-alpha-steroid 4-dehydrogenase activity and cholestenone 5-alpha-reductase activity. Is an ortholog of human SRD5A1 (steroid 5 alpha-reductase 1).
Is predicted to have inositol-polyphosphate 5-phosphatase activity. Is expressed in pharyngeal muscle cell and rectal epithelium. Is an ortholog of human INPP5A (inositol polyphosphate-5-phosphatase A).
Is predicted to have 3-oxo-5-alpha-steroid 4-dehydrogenase activity and cholestenone 5-alpha-reductase activity. Is involved in innate immune response. Is an ortholog of human SRD5A1 (steroid 5 alpha-reductase 1).
Exhibits GTPase activating protein binding activity. Is involved in molting cycle. Is an ortholog of human RABEP1 (rabaptin, RAB GTPase binding effector protein 1).